LIMS & ELN Platforms
Tracks samples, lab workflows, and experiments end to endAutomated experiment documentation with audit-ready recordsBuilt for GxP and 21 CFR Part 11 environments
AkshatMedTech partners with biotech companies to develop HIPAA and 21 CFR Part 11–compliant biotech software, including LIMS, ELNs, and research platforms. We tailor solutions to streamline experiment tracking, automate sample management, and enable real-time analysis of genomics, proteomics, and clinical trial data.
As biotech companies scale, the amount of data they generate increases rapidly but it is scattered and unorganized. This siloed information across labs, devices, and clinical systems often gets in the way of faster discoveries. Many companies struggle to extract actionable insights, weakening their competitive edge. However, AI-enabled biotech software is changing that by unifying data system, accelerating modeling, and delivering real-time insights; capabilities that are becoming critical as the global biotech market is projected to reach USD 3.88 trillion by 2030.
At AkshatMedTech, we build biotech medical software platforms that leverage AI, cloud infrastructure, and data lakes to centralize research, clinical, and operational data. We help transform fragmented systems into an integrated digital ecosystem optimized for speed, security, and scalability. Our solutions include audit-ready logs, digital signatures, and role-based access controls, ensuring full compliance with industry standards and regulatory frameworks.
AkshatMedTech software embeds HIPAA, GxP, and 21 CFR Part 11 compliance directly into workflows, logs, and user access layers.
Our biotech software development services integrate LIMS and ELN modules with sample tracking, lab workflows, and automated experiment documentation.
We deliver biotech software platforms with real-time interoperability between devices, trial systems, and health data pipelines using HL7, FHIR, CDISC, and OMOP standards.
Our platforms use AI to enhance research productivity with automated insights, anomaly detection, and predictive modeling.
Our biotech platforms are built on elastic cloud infrastructure, ready for AI/ML workloads, remote access, and advanced analytics.
Seamlessly connect your biotech IT services with EHRs for clinical trial data sharing, patient recruitment, and real-time health record syncing.
Enable real-time lab data capture by connecting IoT-enabled biotech instruments with custom dashboards and analytics pipelines.
Connect biotech software with CRM systems like Salesforce health cloud integration to track investigator communication, manage trials, and enhance sponsor-CRO collaboration workflows.
Support standardized data exchange by integrating HL7, FHIR, and CDISC models for trial reporting and regulatory submissions.
With 19+ years in digital health, we develop biotech software tailored for lab workflows, data integrity, and compliance.
Align roadmap by defining biotech research goals, users, and compliance.
A healthcare integration project can take from 4 weeks to over 12 months, but the actual time depends on certain parameters. For example, a point-to-point API connection can be completed in 4 to 6 weeks. But a large hospital connecting multiple old platforms can take 6 to 12 months or longer.
Yes, it does reduce costs. A well-thought-through, expert healthcare integration service reduces operational costs by automating manual work. This lessens duplicate data entries and prevents costly errors.
We use HIPAA-aligned security controls, encryption, role-based access, audit logging, and secure data handling throughout the integration lifecycle. Our team tests interfaces before deployment to identify data, access, and security issues before they reach production.
Share a few details and we will come back with a clear, practical next step.
A specialist reviews what you need, so the first reply is relevant, not generic.
Your enquiry goes to the person who knows your area of healthcare.
A free, no-pressure call to understand goals, systems and constraints.
A practical recommendation and scope, with no obligation to proceed.